On the central anti-serotoninergic actions of cyproheptadine and methysergide.
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D003533:Cyproheptadine / Q000494:pharmacology*; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D008784:Methysergide / Q000494:pharmacology*; D011814:Quipazine / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D012702:Serotonin Antagonists; D013696:Temperature; D013997:Time Factors
D012702:Serotonin Antagonists; D003533:Cyproheptadine; D012701:Serotonin; D011814:Quipazine; D006897:Hydroxyindoleacetic Acid; D008784:Methysergide